Innovations in biomarker stratification for precision oncology
Clinical and Experimental Medicine · 28.04.2026 · 26 (1)
DOI: 10.1007/s10238-026-02150-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 28.04.2026. Verfasst von Ronak Naeemaee und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing and Digital Technologies, Sheffield Hallam University, Sheffield, UK. Hauptthemen laut MEDLINE: Precision Medicine, Biomarkers, Tumor, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sheffield Hallam University.
Abstract (Originalsprache)
Biomarker stratification underpins precision oncology, yet survival analysis often relies on arbitrary thresholds that undermine reproducibility and clinical relevance, particularly for continuous biomarkers. This review focuses on methodological approaches for stratifying continuous biomarkers within survival analysis frameworks, examining conventional strategies alongside data-driven and machine learning methods in the context of threshold selection and clinical interpretability. We evaluate the extent to which these approaches address key challenges including heterogeneity, confounding, and overfitting, and critically appraise their strengths and limitations for clinically actionable risk stratification. By synthesising current evidence, we highlight opportunities for more robust and reproducible prognostic modelling and outline future directions to improve the reliability of biomarker-driven decision-making in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computing and Digital Technologies, Sheffield Hallam University, Sheffield, UK.
- School of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK.
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
- Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
- School of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK. l.quayle@shu.ac.uk.
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. l.quayle@shu.ac.uk.
Förderung
- Sheffield Hallam University
Zitieren
APA
Naeemaee, R., Harris, K., Cross, N., Griffin, J., & Quayle, L. A. (2026). Innovations in biomarker stratification for precision oncology. Clinical and Experimental Medicine, 26(1). https://doi.org/10.1007/s10238-026-02150-2
Vancouver
Naeemaee R, Harris K, Cross N, Griffin J, Quayle LA. Innovations in biomarker stratification for precision oncology. Clinical and Experimental Medicine. 2026;26(1). doi:10.1007/s10238-026-02150-2
BibTeX
@article{Naeemaee2026,
author = {Naeemaee, Ronak and Harris, Keith and Cross, Neil and Griffin, Jon and Quayle, Lewis A},
title = {Innovations in biomarker stratification for precision oncology},
journal = {Clinical and Experimental Medicine},
year = {2026},
volume = {26},
number = {1},
doi = {10.1007/s10238-026-02150-2}
}
EUVIMED